%BF; AGE; ANOVA; Advanced glycation end-products; Åldrande; DXA; ECM; ET; Uthållighetsträning; F344BNF1; Fibros; Fischer 344 Brown Norway F1 hybrid rat; GAPDH; Hjärta; LV; MMP; Matrix metalloproteinases; RT-PCR; TIMP; TTBS; Tris-buffered saline (+0.5% Tween); WGA; Advanced glycation end-product; Variansanalys; Dual energy X-ray absorptiometry; Träning; Extracellulär matrix; Glyceraldehyde 3-phosphate dehydrogenase; Vänster kammare; Matrix metalloproteinase; Procent kroppsfett; Reverse transcription polymerase chain reaction; Tissue inhibitor of matrix metalloproteinase; Wheat germ agglutinin.

1 studie om %BF; AGE; ANOVA; Advanced glycation end-products; Åldrande; DXA; ECM; ET; Uthållighetsträning; F344BNF1; Fibros; Fischer 344 Brown Norway F1 hybrid rat; GAPDH; Hjärta; LV; MMP; Matrix metalloproteinases; RT-PCR; TIMP; TTBS; Tris-buffered saline (+0.5% Tween); WGA; Advanced glycation end-product; Variansanalys; Dual energy X-ray absorptiometry; Träning; Extracellulär matrix; Glyceraldehyde 3-phosphate dehydrogenase; Vänster kammare; Matrix metalloproteinase; Procent kroppsfett; Reverse transcription polymerase chain reaction; Tissue inhibitor of matrix metalloproteinase; Wheat germ agglutinin. — granskat, översatt och sammanvävt.